UCLA’s Jonsson Comprehensive Cancer Center
UCLA’s Dr. Joshua G. Cohen is the principal investigator on a multi-campus study launching in the spring
‘I just thought that this was important to me and important to my patients,’ says Tia Wheatley.
‘Immunotherapy effectively has given a fourth pillar of cancer therapy besides surgery, radiation therapy and chemical therapy,’ said UCLA Health’s Dr. Antoni Ribas
Ovarian cancer is the leading cause of gynecologic cancer death in the U.S.
Study was published Dec. 28 in Cell Reports
A UCLA oncologist’s new paper argues against the routine use of anthracycline chemotherapy drugs to treat breast cancer
Decades of discoveries continue to improve patient prognoses
Data suggests it’s the life-saving cancer treatment that increases the risk
'I’m more optimistic than ever about the future for cancer patients,' says the world-renowned expert in gynecologic malignancies